Loading...

Rhythm Pharmaceuticals, Inc.

RYTMNASDAQ
Healthcare
Biotechnology
$86.45
$-0.82(-0.94%)

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Overview

Explore Rhythm Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap5.7B
P/E Ratio-32.03
EPS (TTM)$-2.80
ROE-1.80%
Fundamental Analysis

AI Price Forecasts

1 Week$64.56
1 Month$69.56
3 Months$67.72
1 Year Target$88.50

RYTM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Rhythm Pharmaceuticals, Inc. (RYTM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $88.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -32.03 and a market capitalization of 5.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;